|
1
|
Castleman B and Towne VW: Case records of
the Massachusetts general hospital: Case No. 40231. N Engl J Med.
250:1001–1005. 1954.
|
|
2
|
Simpson D: Epidemiology of castleman
disease. Hematol Oncol Clin North Am. 32:1–10. 2018. View Article : Google Scholar
|
|
3
|
Hoffmann C, Oksenhendler E, Littler S,
Grant L, Kanhai K and Fajgenbaum DC: The clinical picture of
Castleman disease: A systematic review and meta-analysis. Blood
Adv. 8:4924–4935. 2024. View Article : Google Scholar
|
|
4
|
Dispenzieri A and Fajgenbaum DC: Overview
of castleman disease. Blood. 135:1353–1364. 2020. View Article : Google Scholar
|
|
5
|
Carbone A, Borok M, Damania B, Gloghini A,
Polizzotto MN, Jayanthan RK, Fajgenbaum DC and Bower M: Castleman
disease. Nat Rev Dis Primers. 7:842021. View Article : Google Scholar
|
|
6
|
Nikolskaia OV, Nousari CH and Anhalt GJ:
Paraneoplastic pemphigus in association with Castleman's disease.
Br J Dermatol. 149:1143–1151. 2003. View Article : Google Scholar
|
|
7
|
Hematology Committee of Chinese Medical
Association; Hematological Oncology Committee of China Anti-Cancer
Association; China Castleman Disease Network (CCDN), . The
consensus of the diagnosis and treatment of Castleman disease in
China (2021). Zhonghua Xue Ye Xue Za Zhi. 42:529–534. 2021.(In
Chinese).
|
|
8
|
Dong Y, Wang M, Nong L, Wang L, Cen X, Liu
W, Zhu S, Sun Y, Liang Z, Li Y, et al: Clinical and laboratory
characterization of 114 cases of Castleman disease patients from a
single centre: Paraneoplastic pemphigus is an unfavourable
prognostic factor. Br J Haematol. 169:834–842. 2015. View Article : Google Scholar
|
|
9
|
Facchetti F, Simbeni M and Lorenzi L:
Follicular dendritic cell sarcoma. Pathologica. 113:316–329. 2021.
View Article : Google Scholar
|
|
10
|
van Rhee F, Oksenhendler E, Srkalovic G,
Voorhees P, Lim M, Dispenzieri A, Ide M, Parente S, Schey S,
Streetly M, et al: International evidence-based consensus
diagnostic and treatment guidelines for unicentric Castleman
disease. Blood Adv. 4:6039–6050. 2020. View Article : Google Scholar
|
|
11
|
Raja A, Malik K and Mahalingam S: Adrenal
castleman's disease: Case report and review of literature. J Indian
Assoc Pediatr Surg. 27:109–111. 2022. View Article : Google Scholar
|
|
12
|
Chen H, Pang X, Li J, Xu B and Liu Y: Case
Report: A rare case of primary hepatic Castleman's disease
mimicking a liver tumor. Front Oncol. 12:9742632022. View Article : Google Scholar
|
|
13
|
Chen HY, Wu SH, Chew FY and Lee SY:
Mediastinal castleman disease presenting as a paraspinal mass
causing back pain and shortness of breath in a young adult.
Heliyon. 10:e407922024. View Article : Google Scholar
|
|
14
|
Parra-Medina R, Guio JI and López-Correa
P: Localized castleman's disease in the breast in a young woman.
Case Rep Pathol. 2016:84139872016.
|
|
15
|
Boutboul D, Fadlallah J, Chawki S, Fieschi
C, Malphettes M, Dossier A, Gérard L, Mordant P, Meignin V,
Oksenhendler E and Galicier L: Treatment and outcome of unicentric
castleman disease: A retrospective analysis of 71 cases. Br J
Haematol. 186:269–273. 2019. View Article : Google Scholar
|
|
16
|
Fajgenbaum DC, Uldrick TS, Bagg A, Frank
D, Wu D, Srkalovic G, Simpson D, Liu AY, Menke D, Chandrakasan S,
et al: International, evidence-based consensus diagnostic criteria
for HHV-8-negative/idiopathic multicentric Castleman disease.
Blood. 129:1646–1657. 2017. View Article : Google Scholar
|
|
17
|
Liu AY, Nabel CS, Finkelman BS, Ruth JR,
Kurzrock R, van Rhee F, Krymskaya VP, Kelleher D, Rubenstein AH and
Fajgenbaum DC: Idiopathic multicentric Castleman's disease: A
systematic literature review. Lancet Haematol. 3:e163–e175. 2016.
View Article : Google Scholar
|
|
18
|
Zou M, Zhan K, Zhang Y, Li L, Li J, Gao J,
Liu X and Li W: A systematic review of paraneoplastic pemphigus and
paraneoplastic autoimmune multiorgan syndrome: Clinical features
and prognostic factors. J Am Acad Dermatol. 92:307–310. 2025.
View Article : Google Scholar
|
|
19
|
Chen T and Gopal P: Follicular dendritic
cell sarcoma. Arch Pathol Lab Med. 141:596–599. 2017. View Article : Google Scholar
|
|
20
|
Jiménez-Heffernan JA, Díaz Del Arco C and
Adrados M: A cytological review of follicular dendritic
cell-derived tumors with emphasis on follicular dendritic cell
sarcoma and unicentric castleman disease. Diagnostics (Basel).
12:4062022. View Article : Google Scholar
|
|
21
|
Chen R, Teng Y, Xiao Y, Zhang L, Han X,
Wang W, Lu Z and Tian X: Constrictive bronchiolitis and
paraneoplastic pemphigus caused by unicentric Castleman disease in
a young woman: A case report. Front Med (Lausanne). 11:14682512024.
View Article : Google Scholar
|
|
22
|
Zhang MY, Jia MN, Chen J, Feng J, Cao XX,
Zhou DB, Fajgenbaum DC, Zhang L and Li J: UCD with MCD-like
inflammatory state: Surgical excision is highly effective. Blood
Adv. 5:122–128. 2021. View Article : Google Scholar
|
|
23
|
Kaur S, Singh C, Bal A and Jain A:
Unicentric Castleman disease-associated paraneoplastic pemphigus
successfully managed with surgical resection and rituximab. BMJ
Case Rep. 18:e2632752025. View Article : Google Scholar
|
|
24
|
Jain P, Milgrom SA, Patel KP, Nastoupil L,
Fayad L, Wang M, Pinnix CC, Dabaja BS, Smith GL, Yu J, et al:
Characteristics, management, and outcomes of patients with
follicular dendritic cell sarcoma. Br J Haematol. 178:403–412.
2017. View Article : Google Scholar
|
|
25
|
Irrera M, Bozzola E, Cardoni A, DeVito R,
Diociaiuti A, El Hachem M, Girardi K, Marchesi A and Villani A:
Paraneoplastic pemphigus and Castleman's disease: A case report and
a revision of the literature. Ital J Pediatr. 49:332023. View Article : Google Scholar
|
|
26
|
Chinese Society of Dermatology CDA,
Dermatology Branch of China International Exchange, Promotive
Association for Medical and Health Care, Rare Skin Diseases
Committee, China Alliance for Rare Diseases, National Clinical
Research Center for Dermatologic and Immunologic Diseases, . Expert
consensus on the diagnosis and treatment of paraneoplastic
pemphigus in China (2025 version). Chin J Dermatol. 58:289–296.
2025.(In Chinese).
|
|
27
|
Falvo MJ, Sotolongo AM, Osterholzer JJ,
Robertson MW, Kazerooni EA, Amorosa JK, Garshick E, Jones KD,
Galvin JR, Kreiss K, et al: Consensus statements on
deployment-related respiratory disease, inclusive of constrictive
bronchiolitis. Chest. 163:599–609. 2023. View Article : Google Scholar
|
|
28
|
Antiga E, Bech R, Maglie R, Genovese G,
Borradori L, Bockle B, Caproni M, Caux F, Chandran NS, Corrà A, et
al: S2k guidelines on the management of paraneoplastic
pemphigus/paraneoplastic autoimmune multiorgan syndrome initiated
by the European academy of dermatology and venereology (EADV). J
Eur Acad Dermatol Venereol. 37:1118–1134. 2023. View Article : Google Scholar
|
|
29
|
Chen W, Zhao L, Guo L, Zhao L, Niu H, Lian
H, Dai H, Chen J and Wang C: Clinical and pathological features of
bronchiolitis obliterans requiring lung transplantation in
paraneoplastic pemphigus associated with Castleman disease. Clin
Respir J. 16:173–181. 2022. View Article : Google Scholar
|
|
30
|
Liu YT, Zhen JF, Gao YH, Li SY, Dang Y, Xu
HY, Zhang L and Li J: Unicentric Castleman disease complicated with
bronchiolitis obliterans: A single-centre retrospective study from
China. Br J Haematol. 206:1129–1135. 2025. View Article : Google Scholar
|
|
31
|
Yue B, Huang J, Jing L, Yu H, Wei D, Zhang
J, Chen W and Chen J: Bilateral lung transplantation for Castleman
disease with end-stage bronchiolitis obliterans. Clin Transplant.
36:e144962022. View Article : Google Scholar
|
